date,title,source
Oct-18-18,Rocket Pharmaceuticals Presents Updated Long-Term Phase 1/2 Clinical Data of RP-L102 in Fanconi Anemia Patients at the 2018 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT),Business Wire
Oct-19-18,Rocket Pharmaceuticals Presents Preclinical Data at the 2018 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT),Business Wire
Nov-01-18,Rocket Pharmaceuticals Announces Participation at Upcoming Conferences,Business Wire
